XU Jian-ming, ZHANG Hua. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2006.05.006
|
Citation:
|
XU Jian-ming, ZHANG Hua. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2006.05.006
|
XU Jian-ming, ZHANG Hua. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2006.05.006
|
Citation:
|
XU Jian-ming, ZHANG Hua. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 274-276. DOI: 10.3969/j.issn.1671-5144.2006.05.006
|
DownLoad: